Susquehanna Fundamental Investments, LLC Invitae Corp Transaction History

Susquehanna Fundamental Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.71 - $3.61 $48,239 - $101,838	28,210 Added 78.38%	64,200 $119,000
Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $55,480 - $251,996	-29,200 Reduced 44.79%	35,990 $89,000
Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $958,293 - $1.87 Million	65,190 New	65,190 $995,000
Q3 2021 Nov 15, 2021	SELL	$24.31 - $33.6 $1.19 Million - $1.65 Million	-49,132 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$26.09 - $40.4 $273,292 - $423,190	10,475 Added 27.1%	49,132 $1.66 Million
Q1 2021 May 17, 2021	BUY	$33.06 - $56.93 $223,386 - $384,676	6,757 Added 21.18%	38,657 $1.48 Million
Q3 2020 Nov 16, 2020	BUY	$28.43 - $44.67 $906,917 - $1.42 Million	31,900 New	31,900 $1.38 Million

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.